PPT-Disease Burden, Costs and Access to Valuable Cancer Medicines: 

Author : osullivan | Published Date : 2024-01-03

how the pandemic has influenced the disease burden Bengt Jönsson Professor emeritus Stockholm School of Economics Wednesday 1 July 2020 16301900 CET online

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Disease Burden, Costs and Access to Valu..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Disease Burden, Costs and Access to Valuable Cancer Medicines: : Transcript


how the pandemic has influenced the disease burden Bengt Jönsson Professor emeritus Stockholm School of Economics Wednesday 1 July 2020 16301900 CET online event Launch of the European Parliament  . Steve . MacFeely. Director of Business Statistics & Innovation. Outline of Presentation. 1. CSO . 2. Burden Reduction. 3. Costs. 4. Blockages & Risks. CSO - Mandate. Statistics Act, 1993. To collect, compile, extract and disseminate for statistical purposes, information . Communicable Diseases. The Importance of Communicable Diseases. 40% of the burden of disease in low- and middle-income countries. Disproportionately affect the poor. Enormous economic consequences. Relevance to . On behalf of Philipp Lambach. Considerations in decision making and planning processes for influenza vaccine introduction. Disease. What is influenza burden costing the society?. Vaccine. Are there other . –. lessons from HIV. EPIP, 5 September 2017, Bordeaux. . Ellen ‘t Hoen, LLM. University Medical Centre Groningen, Global Health Unit. @. ellenthoen. www.medicineslawandpolicy.org. Brief history. Major Depressive . Disorder. (MDD). Depression is a chronic, recurring, and progressive disorder affecting . 300-350 million . people worldwide. 1,2. Depression is a highly prevalent disorder. The percentage of people suffering from MDD worldwide was . sustainably and equitably financed. Summary Discussion…1. What information needed to estimate cost program of medicines benefits. MBM . Ned to estimate the total economic cost of setting up a MBM program. England. Infographics. What is a Disability Adjusted Life Year (DALY)?. . 2. The Global Burden of Disease: England - . Infographics. It is a measure of the overall burden of . disease – it . adds the years of life lost due early death and years spent living with disability or ill-health together.. Lower rates of premature death have driven reduction in disease burden in the U.S., after adjusting for age. Age standardized disability adjusted life year (DALY) rate per 100,000 population, 1990 - 2010. Case Management. George Jagoe . EVP, Access & Product Management, MMV. . . The access team at MMV is heavily focused on the needs of control today. 4. Achieving patient impact means addressing many hurdles to access. The number of cancer cases has increased over the past two decades. Variation remains across Europe with Hungary recording over 50% more cancer cases per 100,000 population than Cyprus.. Hofmarcher. , T et al. (2019) Comparator Report on Cancer in Europe 2019 - Disease Burden, Costs and Access to Medicines. IHE Report 2019:7. IHE: Lund, Sweden. For further information, please follow:  . Subjects Included in Study: main stem bronchus) Regional extension (disease extending pleura, trachea, esophagus, with neurologic involvement, hilar nodes) Distant metastasis (disease extending contra The overall share of the total health budget dedicated to cancer care has remained stable over the past 20 years.. Hofmarcher. , T et al. (2019) Comparator Report on Cancer in Europe 2019 - Disease Burden, Costs and Access to Medicines. IHE Report 2019:7. IHE: Lund, Sweden. For further information, please follow:  . Hofmarcher. , T et al. (2019) Comparator Report on Cancer in Europe 2019 - Disease Burden, Costs and Access to Medicines. IHE Report 2019:7. IHE: Lund, Sweden. For further information, please follow:  . Disease . October 2022. The results can effectively help industry, policy-makers, healthcare managers, clinicians and patients to address:. Clinical management of the disease. Cost containment measures.

Download Document

Here is the link to download the presentation.
"Disease Burden, Costs and Access to Valuable Cancer Medicines: "The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

Related Documents